Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase 1/2 3 Phase 3 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 314 Carcinoma, Non-Small-Cell Lung 162 Breast Neoplasms 125 Neoplasm Metastasis 106 Melanoma 95 Leukemia, Myeloid, Acute 80 Lymphoma 79 Multiple Myeloma 74 Colorectal Neoplasms 73 Ovarian Neoplasms 70 Lymphoma, Non-Hodgkin 63 Recurrence 58 Prostatic Neoplasms 56 Pancreatic Neoplasms 51 Lung Neoplasms 50 Carcinoma, Renal Cell 40 Glioblastoma 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Lymphoma, Large B-Cell, Diffuse 37 Leukemia, Lymphocytic, Chronic, B-Cell 37 Advanced Solid Tumors 37 Leukemia 36 Myelodysplastic Syndromes 35 Triple Negative Breast Neoplasms 34 Head and Neck Neoplasms 33 Sarcoma 31 Brain Neoplasms 31 Urinary Bladder Neoplasms 30 Stomach Neoplasms 30 Lymphoma, Follicular 28

Interventions

Sirolimus 1 Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Has results × Lymphangioleiomyomatosis × Clear all

NCT01687179 2018-10-11

SAIL

Brigham and Women's Hospital

Phase 1 Completed

14 enrolled 14 charts

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡